545.8500 -19.55 (-3.46%)
NSE Jan 19, 2026 09:07 AM
Volume: 91
 

545.85
-3.46%
Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
More from Solara Active Pharma Sciences Ltd.
Recommended